Sireesh Appajosyula, Chief Operating Officer at Hepion Pharmaceuticals, Inc. (HEPA), bought 2,000,000 shares at $0.05 ($100K) on 2026-08-03, disclosed to the SEC on 2026-08-12.
Hepion Pharmaceuticals COO Sireesh Appajosyula executed a rare $100k purchase of 2M shares at $0.05, marking the largest insider trade in the company's history and signaling strong conviction in the stock's recovery potential. This high-value buy comes at a time when the stock is trading near its 52-week high, suggesting the insider views current valuation as attractive despite recent flat price action.
HEPA is currently trading at $0.3181, representing a 0.03% distance from its 52-week high of $0.3181 and a 0.0% change over the last 5, 30, and 90 days, indicating a consolidation phase near the top of its recent range.
Insider cluster momentum: The trade is flagged as 'is_largest_ever', a significant signal for traders to monitor. Additionally, the stock is currently trading at its 52-week high, which often precedes a breakout or consolidation phase.
Short interest risk: The stock has a short interest of 4.1% of the float, which could lead to volatility if the stock moves sharply higher, potentially triggering short covering rallies or squeeze dynamics.
Clearly above the average filing.
| Filing → |
| THAR | BUY | 2024-11-13 | $10K | — | Filing → |
| THAR | BUY | 2024-10-09 | $10K | — | Filing → |